Source: Covexit.com
We are pleased to present a webinar about a crucial topic: the early treatment of those catching COVID-19, especially with the Delta variant.
The Delta, which represents the vast majority of new cases in the US and many other countries, requires indeed a slightly different approach for its early treatment.
Four distinguished medical doctors, not only highly knowledgeable with the treatment of COVID-19, but also with direct experience in treating patients with Delta, participated in the event: Dr Ryan Cole from Idaho, USA, Dr Shankara Chetty from South Africa, Dr Pierre Kory, from NY, USA, and Dr Richard Urso from Texas, USA.
Dr. Ryan Cole is a board-certified dermatopathologist (AP & CP) and the CEO/Medical Director of Cole Diagnostics. He has worked as an independent pathologist since 2004.
Some highlights from his CV:
Ackerman Academy of Dermatopathology (July 2002-June 2003): Dermatopathology Fellowship (Chief Fellow).
Mayo Clinic (July 1997-June 2002): Resident in Anatomic and Clinical Pathology. Chief Fellow, Surgical Pathology Fellowship. Medical College of Virginia (1993-1997): Researched immunology. Served as President of Student Family Practice organization. Coordinated activities and seminars on the practice of family medicine and rural medicine. Earned MD in 1997.
Related:
The Early Treatment of Delta: Part 3 – Dr Pierre Kory
The Early Treatment of Delta: Part 4 – Dr Richard Urso
‘It’s crystal clear’: Professor Robert Clancy backs ivermectin as a COVID-19 treatment
USA: Omaha Doctor Sees Tremendous Success with Ivermectin as Early Treatment Against COVID-19
Study: Ivermectin can lead to “large reductions” in Covid-19 deaths